跳至主要内容
临床试验/ACTRN12612001067864
ACTRN12612001067864已完成4 期

A randomised controlled pilot trial to evaluate the efficacy of fluoxetine in maintaining remission in Crohn's disease

niversity of South Australia0 个研究点目标入组 52 人开始时间: 2012年10月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria
  • Patients had to meet ALL of the following criteria:
  • 1). Established diagnosis of CD;
  • 2). Remission or only mild symptoms of CD (CDAI <150);
  • 3). Have flared CD in the last 12 months (as documented by their treating doctor and demonstrated by either raised inflammatory markers, augmented therapy, high CDAI or calprotectin);
  • 4). Be on stable dose of all their current CD therapies for 12 weeks;
  • 5). Be 18 years old or older;
  • 6). Have a sufficient knowledge of English to understand and answer questionnaires.
  • 7). Have the ability to consent to the study.

排除标准

  • Exclusion criteria
  • Patients were excluded if they met ANY of the following:
  • 1). Have serious uncontrolled mental illness (e.g. schizophrenia) or are alcohol/substance dependant;
  • 2). Currently taking antidepressants;
  • 3). Currently receiving psychotherapy;
  • 4). Currently taking steroids >15mg or equivalent;
  • 5). Are allergic to fluoxetine or any component of placebo;
  • 6). Are pregnant or breastfeeding;
  • 7). Have cognitive impairment.

研究者

发起方
niversity of South Australia

相似试验